Chengzhi Co Ltd

Chengzhi's capital structure shows a debt-to-equity ratio of 0.37, below the median for Commodity Chemicals firms, and a current ratio of 1.41, indicating moderate liquidity. The company's price-to-book ratio of 0.77 suggests undervaluation relative to tangible assets, but negative net income of CNY -78.14 million and a negative ROE of -0.44% highlight earnings pressure. Profitability metrics show a gross margin of 13.0% (CNY 1.43 billion gross profit on CNY 11.03 billion revenue), but operating income of CNY 124.28 million and a negative ROA of -0.28% indicate weak asset efficiency. These figures fall below the industry median for EBITDA margins and ROIC, reflecting operational underperformance. Revenue is concentrated across four segments: Clean Energy (industrial gases and liquid chemicals), Semiconductor Display Materials (liquid crystal and OLED materials), Life Healthcare (D-ribose and hemp products), and Other (TFT/ITO glass). No segment accounts for more than 50% of revenue, but disclosed segmental breakdowns are absent, limiting visibility into geographic or product concentration. Outlook data shows a projected revenue decline in the current fiscal year, with negative free cash flow of CNY -300.89 million and capital expenditures of CNY -827.48 million. Analysts expect a modest EPS improvement to 0.13 CNY, but the last actual EPS was -0.06 CNY, signaling ongoing earnings volatility. Risk factors include medium liquidity risk due to negative net cash after debt, and a composite risk score reflecting operational and capital structure vulnerabilities. Dilution risk is low, with no difference between basic and diluted shares outstanding, but the company's negative net income and high capex may pressure future capital structure. Recent filings show no material events in the last 90 days, but the company's negative net income and high capex suggest ongoing operational stress. No recent earnings call transcripts or 10-K risk factors are available in the input data.